OpenClinica, LLC v. Evidilya, S.R.L.

CourtDistrict Court, D. Massachusetts
DecidedApril 16, 2026
Docket1:24-cv-11555
StatusUnknown

This text of OpenClinica, LLC v. Evidilya, S.R.L. (OpenClinica, LLC v. Evidilya, S.R.L.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
OpenClinica, LLC v. Evidilya, S.R.L., (D. Mass. 2026).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

OPENCLINICA, LLC, Plaintiff,

v. No. 24-cv-11555-DLC

EVIDILYA, S.R.L., Defendant.

MEMORANDUM AND ORDER ON DIVERSITY JURISDICTION

CABELL, U.S.M.J. In this breach of contract dispute based on diversity jurisdiction, plaintiff OpenClinica, LLC, a company that licenses software and provides related services to conduct clinical trials, alleges that defendant Evidilya, S.R.L., an Italian company which coordinates clinical studies, breached a Master Subscription Agreement (the Master Agreement). In a prior filing, defendant asserted that a limitation of liability provision (LOL) in the Master Agreement raised doubts regarding the existence of diversity jurisdiction anent the $75,000 threshold.1 As instructed, the parties submitted briefs on the matter and the issue is therefore ripe for review. For the reasons that follow,

1 In that regard, the LOL limits defendant’s aggregate liability (and therefore plaintiff’s recovery) to the amount of fees paid and payable to plaintiff by defendant during a twelve-month period prior to the time the claim arose. plaintiff satisfies its burden to establish the amount-in- controversy requirement. I. LEGAL STANDARD “The party invoking diversity jurisdiction bears the burden of establishing that the amount-in-controversy requirement is

satisfied.” Andersen v. Vagaro, Inc., 57 F.4th 11, 14 (1st Cir. 2023). Ordinarily, the amount is determined “from the complaint itself, unless it appears or is [demonstrated] that the amount stated . . . is not claimed in good faith.” Horton v. Liberty Mut. Ins., Co., 367 U.S. 348, 353 (1961); Kersey v. Peoples’ United Bank, N.A. of Ct., No. 16-cv-12414-PBS, 2017 WL 8730466, at *3 (D. Mass. Nov. 7, 2017) (quoting Horton, 367 U.S. at 353, in parenthetical). “[W]hen challenged,” however, “the plaintiff ‘has the burden of alleging with sufficient particularity facts indicating that it is not a legal certainty that the claim involves less than the jurisdictional amount.’” Andersen, 57 F.4th at 15 (citations omitted); Id. (“[P]laintiff, when challenged, must

provide ‘competent proof’ supporting jurisdictional claim” (citing McNutt v. Gen. Motors Acceptance Corp. of Ind., 298 U.S. 178, 189 (1936)) (additional citation omitted). In meeting that burden, the plaintiff should provide “additional documentation, such as affidavits” or other competent proof. Id. (citations omitted). II. BACKGROUND2 In October 2021, plaintiff and defendant entered into the Master Agreement. As stated therein, plaintiff agreed to provide defendant with “Subscription Services” for clinical research studies carried out by defendant. (D. 30-1) (Master Agreement

stating “OpenClinica will provide [defendant] with Subscription Services for Subscriber Studies . . . .”); (D. 30-1) (Master Agreement defining “Subscription Services” as those set out in an order form); (D. 30-1) (Master Agreement defining “Subscriber’s Studies” as “clinical research studies carried out by Subscriber,” i.e., defendant). Defendant, in turn, agreed to pay plaintiff the fees stated in an order form in accordance with the schedule in the form. (D. 30-1) (Master Agreement stating “Subscriber,” i.e., defendant, will pay OpenClinica fees as stated on the Order Form . . . in accordance with the payment schedule set forth on the Order Form . . . .”). At the time the parties executed the Master Agreement they

entered into their first order form. (D. 30, ¶ 4) (D. 30-2). The October 2021 order form set out a thirty-six month term during which plaintiff allowed defendant to use two of its software products for $3,500 per month.3 (D. 30-2, p. 2) (D. 30, ¶ 4). As

2 The background is culled from additional documentation as opposed to the complaint.

3 The order form also allowed defendant to use two more software products for twenty-four months. stated in the order form, plaintiff would bill defendant annually for these subscription services. In practice, the parties changed the annual billing to monthly billing at defendant’s request. (D. 30, ¶ 6). Defendant’s payment was due within thirty days of the date of

an invoice. (D. 30-2). Further, defendant incurred a 1.5% late fee on past due amounts pending more than thirty days. (D. 30-2, p. 4) (D. 30, ¶ 5). Defendant failed to pay at least a dozen invoices in a timely manner, if at all. (D. 30-4). In February 2023, and with the parties still operating under the October 2021 order form because of the thirty-six month term, the parties entered into another order form involving a second research study carried out by defendant. (D. 30, ¶ 8). Like the October 2021 order form, the February 2023 order form imposed a 1.5% late fee if defendant failed to pay an invoice within thirty days. (D. 30-3). The form set out a quarterly billing structure. (D. 30-3) (order form stating “Subscription items billed quarterly

in advance”); (D. 30, ¶ 10). At defendant’s request, however, plaintiff billed defendant on a monthly basis.4 (D. 30, ¶ 9). The start date for the services in the February 2023 order form was January 2, 2023. (D. 30-3) (D. 30, ¶ 8). To continue, from December 2022 to August 2023 plaintiff sent defendant eight

4 The monthly invoice corresponded to a three-month period. (D. 30, ¶ 10). invoices which remain unpaid. The invoiced amount totals $52,109 excluding late fees. (D. 30-4). From August to October 2023, plaintiff issued defendant four more invoices which also remain unpaid. These invoices total $24,030 yielding a total amount of $76,139 for the December 2022 to October 2023 period. Late fees

for the foregoing unpaid fees total $2,833.50 up to October 2023. (D. 30-4). In late December 2023, plaintiff sent defendant three more invoices which remain unpaid. These invoices totaled $15,250 and remain unpaid. (D. 30-4). III. DISCUSSION As previously noted, the LOL limits defendant’s liability (and therefore plaintiff’s recovery) to the amount of fees paid and payable to plaintiff during a twelve-month period. As such, the LOL plays a critical role in assessing the $75,000 amount-in- controversy requirement. In pertinent part, the LOL reads as follows: The total aggregate liability of either party . . . for any claims or causes of action arising under [the Master Agreement] will not exceed the aggregate amount of the fees5 paid and payable to OpenClinica by [defendant] during the twelve (12) month period preceding the date on which the claim arises.

(D. 23) (emphasis added). The parties dispute when the breach of the Master Agreement claim arose and the applicable twelve-month

5 The term “fees” means the “fees as stated on the Order Form . . . .” (D. 30- 1, p. 4). lookback period.6 (D. 29) (plaintiff’s brief surmising that contract claim arose in October 2023 warranting October 2022 to October 2023 lookback period); (D. 33) (defendant’s brief asserting claim arose in August 2023 warranting August 2022 to August 2023 lookback period).7 The court therefore addresses the

meaning of when “the claim arises.” Thereafter, the court identifies the twelve-month lookback period and calculates the jurisdictional amount. A. WHEN THE CLAIM ARISES As noted, the LOL limits the recoverable fees to the twelve- month period preceding “the date on which the claim arises.” (D. 30-1, p. 8). Plaintiff maintains this language is ambiguous. (D. 29, pp. 4-5). As discussed below, it is not.

6 The three-count complaint sets out three causes of action: breach of the Master Agreement, quantum meruit, and promissory estoppel.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McNutt v. General Motors Acceptance Corp.
298 U.S. 178 (Supreme Court, 1936)
Horton v. Liberty Mutual Insurance
367 U.S. 348 (Supreme Court, 1961)
Anthony Artuso v. Vertex Pharmaceuticals, Inc.
637 F.3d 1 (First Circuit, 2011)
Strand v. Herrick & Smith
489 N.E.2d 179 (Massachusetts Supreme Judicial Court, 1986)
Bosque v. Wells Fargo Bank, N.A.
762 F. Supp. 2d 342 (D. Massachusetts, 2011)
Balles v. Babcock Power Inc.
70 N.E.3d 905 (Massachusetts Supreme Judicial Court, 2017)
A.L. Prime Energy Consultant, Inc. v. Mass. Bay Transportation Authority
95 N.E.3d 547 (Massachusetts Supreme Judicial Court, 2018)
Suffolk Construction Co. v. Illinois Union Insurance
951 N.E.2d 944 (Massachusetts Appeals Court, 2011)
Andersen v. Vagaro, Inc.
57 F.4th 11 (First Circuit, 2023)
DraftKings Inc. v. Hermalyn
118 F.4th 416 (First Circuit, 2024)
Moncada Alaniz v. Bay Promo, LLC
143 F.4th 18 (First Circuit, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
OpenClinica, LLC v. Evidilya, S.R.L., Counsel Stack Legal Research, https://law.counselstack.com/opinion/openclinica-llc-v-evidilya-srl-mad-2026.